Results 181 to 190 of about 4,271 (264)
China's Legal Protection System for Pangolins: Past, Present, and Future. [PDF]
Su D, Wu K, Nie A.
europepmc +1 more source
Knowledge sourcing, geopolitics, and FDI: An empirical analysis on the US green and digital sectors
Abstract Research Summary This paper examines how foreign direct investment (FDI) shapes firms' sourcing of knowledge in the digital and green domains under rising geopolitical frictions. We assemble a firm–country dyadic panel (2013–2020) linking US patent backward citations to firms' FDI, enriched with bilateral geopolitical distance and host‐country
Alberto Maria Radici
wiley +1 more source
The therapeutic futility paradox: insights from oncological drug litigation in Ecuador. [PDF]
Mena Ayala MB, Maldonado X.
europepmc +1 more source
Abstract Research Summary This article develops a conceptual framework for understanding multinational enterprise (MNE) resilience in the era of cascading crises. We define resilience as the MNE's capacity to absorb disruption, maintain or restore functioning, and reconfigure operations as conditions shift.
Gerard George, Chang Hoon Oh
wiley +1 more source
Judicial demands for prostate cancer treatment in Brazil: androgen receptor pathway inhibitors are an urgent public health problem. [PDF]
Silveira MAD +8 more
europepmc +1 more source
Geopolitics and global strategy: Making money under anarchy
Abstract Research Summary Multinational firms conduct cross‐border trade and investment in a world of anarchy, where nation‐states must secure their survival in the absence of a world government. We develop a geopolitical‐economic order (GEO) framework to argue that the extent of geopolitical competition incentivizes states to create one of two types ...
Daniel J. Blake +2 more
wiley +1 more source
Marrying for power: Gendered alliances in mafias. [PDF]
Catino M, Aziani A, Rocchi S.
europepmc +1 more source
Pharmaceutical Pricing and R&D as a Global Public Good
ABSTRACT This paper examines the international variation in the prices of branded pharmaceuticals. We consider short‐run profits, or quasi‐rents, as representing each country's contribution toward the global public good of therapeutic information embodied in new pharmaceuticals.
H. E. Frech III +3 more
wiley +1 more source

